menu
    • menu

    Company profile for Enyo Pharma

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ENYO Pharma is a clinical stage Biotech with a unique drug discovery engine inspired by viruses. The company is currently entering Phase 2 with its lead compound EYP001 (a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreove...
    ENYO Pharma is a clinical stage Biotech with a unique drug discovery engine inspired by viruses. The company is currently entering Phase 2 with its lead compound EYP001 (a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH.Several additional innovative drug discovery programs are progressing speedily towards non-Clinical Development; their human targets being yet untapped by Pharma’s, these programs can moreover be developed for various indications

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Enyo PharmaFrance Flag
    Country
    Country
    France
    Address
    Address
    Bâtiment Domilyon 321 avenue Jean Jaurès 69007 LYON, FRANCE
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.enyopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/enyo-pharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/enyopharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ENYO Pharma Reveals Phase 2 Alpestria-1 Study: Vonafexor
    ENYO Pharma Reveals Phase 2 Alpestria-1 Study: Vonafexor

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108991230/en/ENYO-Pharma-Announces-Completion-and-Topline-Data-From-Phase-2-Alpestria-1-Clinical-Study-in-Alport-Syndrome-Demonstrating-Vonafexor-Reverses-Kidney-Function-Decline-and-Has-Sustained-Therapeutic-Benefit

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    ENYO Pharma Completes Series C Financing with Vesalius Biocapital
    ENYO Pharma Completes Series C Financing with Vesalius Biocapital

    12 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250612279577/en/ENYO-Pharma-Announces-Completion-of-Series-C-Financing-With-Vesalius-Biocapital-and-Continued-Progress-of-Its-ALPESTRIA-1-Clinical-Phase-2-Study-in-Alport-Syndrome-Patients

    BUSINESSWIRE
    12 Jun 2025
    Share Share
    ENYO Pharma Announces Two Vonafexor Data Presentations at AASLD
    ENYO Pharma Announces Two Vonafexor Data Presentations at AASLD

    03 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211103005709/en

    BUSINESSWIRE
    03 Nov 2021
    Share Share
    ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results
    ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results

    30 Jul 2021

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20210730005079/en

    BUSINESS WIRE
    30 Jul 2021
    Share Share
    ENYO Pharma Announce +Ve Vonafexor Results for the LIVIFY Phase 2a Study
    ENYO Pharma Announce +Ve Vonafexor Results for the LIVIFY Phase 2a Study

    29 Jul 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210728005557/en

    BUSINESSWIRE
    29 Jul 2021
    Share Share
    Enyo Pharma notches a mid-stage trial win in tricky NASH
    Enyo Pharma notches a mid-stage trial win in tricky NASH

    28 Jul 2021

    // Annalee Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/enyo-pharma-s-nash-results-show-boost-kidney-function-differentiating-vonafexor-from-busy

    Annalee Armstrong FIERCEBIOTECH
    28 Jul 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search